Sedation of Adults with Orally Administered Midazolam in Dentistry – A Retrospective Study
DOI:
https://doi.org/10.2340/aos.v83.41403Keywords:
Adults, dental care, midazolam, retrospective studyAbstract
Objective: The use of midazolam (MZ) has increased in dentistry, but the effect in adults is sparsely studied. The aim of this study was to investigate doses, effects, and side effects of orally administered MZ as a sedative for adults in a dental care organization.
Material and methods: A retrospective record review was performed including all adult patients in the dental care organization ≥20 years receiving MZ, identified through a logbook for addictive drugs, during 2020. From patients’ records, the following data were extracted: age, gender, medical history, reason for sedation, performed treatments, doses, effects, and side effects of MZ.
Results: In total, 265 patients on 418 occasions had been sedated, which constituted 2.3 sedations per 1,000 visits and 3.3 sedations per 1,000 treated patients. Mean age was 40.8 years and 67.7% were females. The most common reason for sedation was anxiety. Mean dose in primary dental clinics was 7.9 mg and in specialist clinics, 6.8 mg (p < 0.001). Older patients (>70 years) had lower doses than younger (p < 0.001), while no difference was found between ages 55–70 years and those who were younger. Dental treatment was completed in 91.9% of occasions, and side effects were registered in 2.2%. Successful dental treatment was related to type of treatment performed.
Conclusions: Sedation is rarely used, particularly in primary dental care, and the use varies widely between clinics. MZ administered by dentists seems to be safe and effective. A sedation record should be used to make patient data such as weight and medical conditions available.
Downloads
References
Boyle CA, Manley MC, Fleming GJ. Oral midazolam for adults with learning disabilities. Dent Update. 2000;27(4):190–2. https://doi.org/10.12968/denu.2000.27.4.190 DOI: https://doi.org/10.12968/denu.2000.27.4.190
Rignell L, Mikati M, Wertsén M, Hägglin C. Sedation with orally administered midazolam in elderly dental patients with major neurocognitive disorder. Gerodontology. 2017;34(3):299–305. https://doi.org/10.1111/ger.12262 DOI: https://doi.org/10.1111/ger.12262
Svensson L, Hakeberg M, Boman UW. Dental anxiety, concomitant factors and change in prevalence over 50 years. Community Dent Health. 2016;33(2):121–6.
Wide Boman U, Carlsson V, Westin M, Hakeberg M. Psychological treatment of dental anxiety among adults: a systematic review. Eur J Oral Sci. 2013;121(3 Pt 2):225–34. https://doi.org/10.1111/eos.12032 DOI: https://doi.org/10.1111/eos.12032
Burghardt S, Koranyi S, Magnucki G, Strauss B, Rosendahl J. Non-pharmacological interventions for reducing mental distress in patients undergoing dental procedures: systematic review and meta-analysis. J Dent. 2018;69:22–31. https://doi.org/10.1016/j.jdent.2017.11.005 DOI: https://doi.org/10.1016/j.jdent.2017.11.005
Coulthard P. Medical management of dental anxiety. Prim Dent J. 2019;19;7(4):40–4. https://doi.org/10.1177/205016841800700410 DOI: https://doi.org/10.1177/205016841800700410
Patodia S, LeBlanc V, Haas DA, Dempster LJ. Ontario dentists’ estimation of patient interest in anesthesia. J Can Dent Assoc. 2017;82:h2.
Patodia S, LeBlanc V, Dempster LJ. Ontario dentists’ practice of sedation and general anesthesia: barriers to access and use. J Can Dent Assoc. 2021;87:l2.
Practice guidelines for moderate procedural sedation and analgesia 2018: a report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology. Anesthesiology. 2018;128(3):437–79. https://doi.org/10.1097/ALN.0000000000002043 DOI: https://doi.org/10.1097/ALN.0000000000002043
Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology. 1985;62(3):310–24. https://doi.org/10.1097/00000542-198503000-00017 DOI: https://doi.org/10.1097/00000542-198503000-00017
Conway A, Chang K, Mafeld S, Sutherland J. Midazolam for sedation before procedures in adults and children: a systematic review update. Syst Rev. 2021;5;10(1):69. https://doi.org/10.1186/s13643-021-01617-5 DOI: https://doi.org/10.1186/s13643-021-01617-5
Heard C, Smith J, Creighton P, Joshi P, Feldman D, Lerman J. A comparison of four sedation techniques for pediatric dental surgery. Paediatr Anaesth. 2010;20(10):924–30. https://doi.org/10.1111/j.1460-9592.2010.03402.x DOI: https://doi.org/10.1111/j.1460-9592.2010.03402.x
Conway A, Rolley J, Sutherland JR. Midazolam for sedation before procedures. Cochrane Database Syst Rev. 2016;20;2016(5):CD009491. https://doi.org/10.1002/14651858.CD009491.pub2 DOI: https://doi.org/10.1002/14651858.CD009491.pub2
American Society of Anesthesiologists. ASA physical status classification system. [cited 2023 Aug 28] Available from: https://www.asahq.org/standards-and-practice-parameters/statement-on-asa-physical-status-classification-system
Uldum B, Hallonsten AL, Poulsen S. Midazolam conscious sedation in a large Danish municipal dental service for children and adolescents. Int J Paediatr Dent. 2008;18(4):256–61. https://doi.org/10.1111/j.1365-263X.2007.00902.x DOI: https://doi.org/10.1111/j.1365-263X.2007.00902.x
Papineni McIntosh A, Ashley PF, Lourenço-Matharu L. Reported side effects of intravenous midazolam sedation when used in paediatric dentistry: a review. Int J Paediatr Dent. 2015;25(3):153–64. https://doi.org/10.1111/ipd.12127 DOI: https://doi.org/10.1111/ipd.12127
Region Uppsala [Internet]. Midazolam vuxna, riktlinjer, FTV. Swedish. [cited 2024 Feb 08]. Available from: https://ltuppsala.sharepoint.com/sites/DocPlusSTYR/Publicerade/Intern%20ut%C3%B6kad/Midazolam,%20vuxna,%20riktlinjer,%20FTV.pdf
Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921–30. https://doi.org/10.1111/bcp.14094 DOI: https://doi.org/10.1111/bcp.14094
Hägglin C, Berggren U, Hakeberg M, Hällström T, Bengtsson C. Variations in dental anxiety among middle-aged and elderly women in Sweden: a longitudinal study between 1968 and 1996. J Dent Res. 1999;78(10):1655–61. https://doi.org/10.1177/00220345990780101101 DOI: https://doi.org/10.1177/00220345990780101101
Norderyd O, Kochi G, Papias A, Köhler AA, Helkimo AN, Brahm CO et al. Oral health of individuals aged 3–80 years in Jönköping, Sweden, during 40 years (1973–2013). I. Review of findings on oral care habits and knowledge of oral health. Swed Dent J. 2015;39(2):57–68.
Hauge MS, Stora B, Vassend O, Hoffart A, Willumsen T. Dentist-administered cognitive behavioural therapy versus four habits/midazolam: an RCT study of dental anxiety treatment in primary dental care. Eur J Oral Sci. 2021;129(4):e12794. https://doi.org/10.1111/eos.12794 DOI: https://doi.org/10.1111/eos.12794
Li X, Liu Y, Li C, Wang J. Sedative and adverse effect comparison between oral midazolam and nitrous oxide inhalation in tooth extraction: a meta-analysis. BMC Oral Health. 2023; 20;23(1):307. https://doi.org/10.1186/s12903-023-02965-5 DOI: https://doi.org/10.1186/s12903-023-02965-5
Gabre P, Martinsson T, Gahnberg L. Longitudinal study of dental caries, tooth mortality and interproximal bone loss in adults with intellectual disability. Eur J Oral Sci. 2001 Feb;109(1):20–6. https://doi.org/10.1034/j.1600-0722.2001.00965.x DOI: https://doi.org/10.1034/j.1600-0722.2001.00965.x
Manley MC, Ransford NJ, Lewis DA, Thompson SA, Forbes M. Retrospective audit of the efficacy and safety of the combined intranasal/intravenous midazolam sedation technique for the dental treatment of adults with learning disability. Br Dent J. 2008;26;205(2):E3;discussion 84–5. https://doi.org/10.1038/sj.bdj.2008.521 DOI: https://doi.org/10.1038/sj.bdj.2008.521
Araújo JO, Bergamaschi CC, Lopes LC, Guimarães CC, de Andrade NK, Ramacciato JC et al. Effectiveness and safety of oral sedation in adult patients undergoing dental procedures: a systematic review. BMJ Open. 2021; 25;11(1):e043363. https://doi.org/10.1136/bmjopen-2020-043363 DOI: https://doi.org/10.1136/bmjopen-2020-043363
Mui LM, Teoh AY, Ng EK, Lee Y, Au Yeung ACM, Chan Y et al. Premedication with orally administered midazolam in adults undergoing diagnostic upper endoscopy: a double-blind placebo-controlled randomized trial. Gastrointest Endosc. 2005;61(2):195–200. https://doi.org/10.1016/s0016-5107(04)02590-8 DOI: https://doi.org/10.1016/S0016-5107(04)02590-8
Collado V, Faulks D, Nicolas E, Hennequin M. Conscious sedation procedures using intravenous midazolam for dental care in patients with different cognitive profiles: a prospective study of effectiveness and safety. PLoS One. 2013;5;8(8):e71240. https://doi.org/10.1371/journal.pone.0071240 DOI: https://doi.org/10.1371/journal.pone.0071240
Boyle CA, Newton T, Milgrom P. Who is referred for sedation for dentistry and why? Br Dent J. 2009;28;206(6):E12;discussion 322–3. https://doi.org/10.1038/sj.bdj.2009.251 DOI: https://doi.org/10.1038/sj.bdj.2009.233
Published
Issue
Section
License
Copyright (c) 2024 Marika Storskrubb, Pia Gabre
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Odontologica Scandinavica publishes original research papers as well as critical reviews relevant to the diagnosis, epidemiology, health service, prevention, aetiology, pathogenesis, pathology, physiology, microbiology, development and treatment of diseases affecting tissues of the oral cavity and associated structures including papers on cause and effect or explanatory/associative relationships for experimental or observational studies.
